By name: "KSB-D05-K0011" description: "Risk Assessment Methodologies: Protocol-specific risk evaluation, patient population considerations, investigational product charac..." version: "1.0.0" domain: "D05" domain_name: "Clinical Trials PV" type: "Knowledge" proficiency_level: "L1" bloom_level: "understand" triggers: - "explain risk assessment methodologies" - "what is risk assessment methodologies" - "explain risk assessment methodologies" epa_mapping: "EPA-02, EPA-04, EPA-08" cpa_mapping: "CPA-01, CPA-07" regulatory_refs: "EMA-REG-004, ICH-E6"
KSB-D05-K0011: Risk Assessment Methodologies
Overview
Domain: D05 - Clinical Trials PV Type: Knowledge Proficiency Level: L1 (Novice - Direct supervision required) Bloom Level: Understand
Description
Protocol-specific risk evaluation, patient population considerations, investigational product characteristics
Context
- Major Section: Clinical Trial Regulatory Framework and Safety Requirements
- Section: Risk-Based Monitoring and Quality Assurance
EPA Mapping
- EPA-02:3004-3005
- EPA-04:3009-3010
- EPA-08:3018-3019
CPA Pathway
- CPA-01, CPA-07
Regulatory References
- EMA-REG-004
- ICH-E6
Instructions
When this skill is activated, Claude should:
- Demonstrate L1 proficiency in risk assessment methodologies
- Apply understand level cognitive skills to explain the topic
- Reference relevant regulatory guidance (EMA-REG-004, ICH-E6)
- Connect to related EPAs: EPA-02, EPA-04, EPA-08
Key Competencies
- Protocol-specific risk evaluation, patient population considerations, investigational product characteristics
Assessment Criteria
- Can explain core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D05 skills in Risk-Based Monitoring and Quality Assurance
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31